Parkside Financial Bank & Trust’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
TI
SCM
DGI
SBH
Parkside Financial Bank & Trust's SRDX Position: Q1 2023 in Review
Parkside Financial Bank & Trust sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 4 shares — an estimated $136 sold.
Parkside Financial Bank & Trust first reported a position in SRDX in Q4 2016 and held it in 24 quarters. The position peaked at $2K in Q2 2022. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.
- Parkside Financial Bank & Trust reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
- Parkside Financial Bank & Trust sold 4 Surmodics shares in Q1 2023, an estimated $136.
- Parkside Financial Bank & Trust first reported a position in Surmodics in Q4 2016 and held it in 24 quarters.
- Parkside Financial Bank & Trust's Surmodics position peaked at $2K in Q2 2022.
- 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2023, filed 4 May 2023.